A large, long-running study has found that consistent heavy drinking over a lifetime is linked to a 91% higher risk of colorectal cancer. The research, which tracked participants for up to 20 years, examined how alcohol consumption from early adulthood through midlife affects colon health.
The study used data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Adults reported their alcohol intake across four life stages, starting at age 18. Researchers calculated average lifetime alcohol intake in drinks per week. Participants were grouped into categories such as consistent light, moderate, or heavy drinkers, as well as former drinkers. The study tracked two outcomes: colorectal cancer and colorectal adenomas, which are benign growths that can turn into cancer. All participants were cancer-free at the start of the study.
Key findings on drinking patterns
Heavy lifetime drinkers, defined as those averaging 14 or more drinks per week throughout their adult lives, had a 25% higher risk of colorectal cancer overall compared to the lightest drinkers, who had less than one drink per week. For rectal cancer specifically, the risk for heavy drinkers was 95% higher.
The most striking finding involved people who were consistent heavy drinkers throughout their lives. These individuals faced a 91% higher risk of colorectal cancer compared to consistent light drinkers, nearly doubling their odds of developing the disease.
Moderate drinkers, those averaging seven to less than 14 drinks per week, actually had a 21% lower risk of colorectal cancer compared to the lightest drinkers, particularly for distal colon cancer. Researchers noted this does not mean moderate drinking is protective. It may reflect other lifestyle factors the study could not fully account for.
Benefits of quitting
Former drinkers had a 42% lower risk of developing non-advanced adenomas compared to current light drinkers. Since adenomas are precursors to most colorectal cancers, this suggests that quitting drinking could interrupt the cancer development process. The timing and relationship in the data strongly suggest that reducing alcohol offers protective benefits.
How alcohol increases cancer risk
When the body breaks down alcohol, it produces acetaldehyde, a compound classified as a carcinogen. This substance directly damages DNA in colon and rectum cells and creates oxidative stress that can lead to cancer-promoting mutations. Acetaldehyde also interferes with how the body absorbs and uses folate, a B vitamin crucial for healthy DNA function. Disrupted folate metabolism can lead to abnormal DNA methylation patterns, which are often early steps toward cancer development.
Alcohol also affects the gut microbiome, potentially disrupting bacteria that influence immune function, inflammation levels, and cell growth in the intestinal lining. Chronic low-grade inflammation creates an environment where abnormal cells can grow and persist, especially with decades of exposure.
Practical implications
Chronic heavy drinking matters. Regularly exceeding 14 drinks per week over many years was consistently linked to higher colorectal cancer risk. Stopping alcohol may lower early risk, as former drinkers showed lower odds of developing non-advanced adenomas. Moderation is not a free pass, as alcohol remains a known carcinogen. Screening remains essential, with protective effects strongest among participants who underwent regular colorectal screening. Colonoscopies are recommended starting at age 45, or earlier for those at higher risk.
Alcohol is only one factor. Fiber intake, physical activity, body composition, and limiting processed meats all play significant roles in colorectal cancer prevention.
Colorectal cancer is showing up in younger adults at alarming rates. The research shows that cumulative drinking patterns throughout adult life matter more than any single period of drinking. The problem is not the occasional glass of wine or beer, but when drinking becomes a daily habit, especially at higher quantities, as risk compounds over decades.
